TUESDAY, 6 FEBRUARY 2018
PRE-CONGRESS DAY FOR NURSES, PHYSIOTHERAPISTS, AND PSYCHOSOCIAL PROFESSIONALS | |
---|---|
10:30 – 17:30 | See Programme |
YOUNG INVESTIGATORS WORKSHOP | |
13:00 – 17:00 | See Programme |
WEDNESDAY, 7 FEBRUARY 2018
MULTIDISCIPLINARY EDUCATIONAL SESSION | Chairs: Jan Blatny and Víctor Jiménez Yuste | Auditorio A / Plenary Hall | |
---|---|---|---|
09:30 – 11:00 | Radiosynovectomy – an important treatment option for patients with target joint | Jan Blatny, Víctor Jiménez Yuste, E. Carlos Rodriguez-Merchan, Sébastien Lobet, Sara Garcia Barcenilla, Daniel Aníbal García Diego | |
11:00 – 11:30 | Coffee Break |
INDUSTRY SPONSORED SESSIONS | |
---|---|
11:30 – 13:00 | Industry sponsored sessions |
13:00 – 14:00 | Lunch Break |
14:00 – 15:30 | Industry sponsored sessions |
15:30 – 16:00 | Coffee Break |
16:00 – 17:30 | Industry sponsored sessions |
17:30 – 18:00 | Coffee Break |
18:00 – 19:30 | Industry sponsored session |
19:30 – 20:30 | WELCOME RECEPTION | Poster & Catering Area |
---|
THURSDAY, 8 FEBRUARY 2018
08:45 – 09:00 | WELCOME AND INTRODUCTION | Víctor Jiménez Yuste and Cédric Hermans | Auditorio A / Plenary Hall |
---|
09:00 – 10:30 | SESSION 1: Inhibitors from Basic Science to Clinical Management | Chairs: Karin Fijn van Draat and Maria Teresa Alvarez-Roman | Auditorio A / Plenary Hall |
---|---|---|---|
09:00 – 09:30 | The role of innate immunology | Eduardo López Collazo | |
09:30 – 10:00 | Prophylaxis in inhibitor patients | Pål Andre Holme | |
10:00 – 10:30 | Is the type of product important in inhibitor development? | Samantha Gouw | |
10:30 – 11:00 | Coffee Break/Poster Viewing | Poster & Catering Area |
11:00 – 12:30 | SESSION 2: Platelets | Chairs: Riitta Lassila and Jose Mateo | Auditorio A / Plenary Hall |
---|---|---|---|
11:00 – 11:30 | Old and novel platelet disorder: experience in the Spanish national project | José Rivera | |
11:30 – 12:00 | Treatment of inherited thrombocytopenia | Carlo Balduini | |
12:00 – 12:30 | Congenital and immune-mediated thrombotic thrombocytopenic purpura | Johanna Kremer Hovinga | |
12:30 – 13:30 | Lunch break/Poster Viewing /EAHAD Annual General Meeting | Poster & Catering Area |
13:30 – 15:00 | SESSION 3: Economics of Haemophilia | Chairs: Philippe de Moerloose and Santiago Bonanad | Auditorio A / Plenary Hall |
---|---|---|---|
13:30 – 14:00 | Pharmacoeconomics of haemophilia care | Lieve Annemans | |
14:00 – 14:30 | EHC PARTNERS Programme | Brian O’Mahony | |
14:30 – 15:00 | Challenges and changes in the plasma products sector | Bruno Santoni | |
15:00 – 15:30 | Coffee Break/Poster Viewing | Poster & Catering Area |
15:30 – 17:00 | SESSION 4: More than Factor Administration | Chairs: Martin Bedford and Ramiro Nuñez | Auditorio A / Plenary Hall |
---|---|---|---|
15:30 – 16:00 | Ultrasound imaging in acute bleeding and haemophilic arthropathy | Carlo Martinoli | |
16:00 – 16:30 | The management of acute musculoskeletal bleeding events | Stephen Classey | |
16:30 – 17:00 | Family-based educational programme on self-management : A structured approach | Piet de Kleijn | |
17:00 – 17:15 | Poster Viewing | Poster Area |
17:15 – 18:45 | SESSION 5: Outside the Joints | Chairs: Hervé Chambost and Javier Batlle | Auditorio A / Plenary Hall |
---|---|---|---|
17:15 – 17:45 | Can we now forget about hepatitis C in haemophilia? | Juan Berenguer | |
17:45 – 18:15 | Intracranial Haemorrhage in inherited bleeding disorders | Ri Liesner | |
18:15 – 18:45 | Women’s issues in inherited bleeding disorders | Sophie Susen | |
20:00 – 00:00 | Congress Networking Evening |
FRIDAY, 9 FEBRUARY 2018
07:45 – 08:30 | MORNING CASE | Chairs: Michael Makris and Cédric Hermans | Auditorio A / Plenary Hall |
---|---|---|---|
New products and rules for switching | Flora Peyvandi |
08:30 – 10:00 | SESSION 6: SLAM | Chairs: Robert Klamroth and Marie Eva Mingot | Auditorio A / Plenary Hall |
---|---|---|---|
OR01 | IMPLEMENTATION OF THE FRENCH PRIMARY LONGTERM PROPHYLAXIS GUIDELINES: A REAL-WORLD PROSPECTIVE STUDY OF THE FRANCECOAG PUPS COHORT | Paul Saultier | |
OR02 | WITHIN-PATIENT COMPARISON OF TREATMENT PATTERNS BEFORE AND AFTER SWITCHING TO RFVIIIFC: A REPORT FROM THE UK NATIONAL HAEMOPHILIA DATABASE | Martin Scott | |
OR03 | INHIBITOR INCIDENCE IN PUPS WITH SEVERE HAEMOPHILIA B IS HIGHER THAN USUALLY REPORTED; DATA FROM THE PEDNET REGISTRY | Marijke Van Den Berg | |
OR04 | COMORBIDITIES EXPLAIN THE AGE-RELATED INCREASE OF VON WILLEBRAND FACTOR IN PATIENTS WITH TYPE 1 VON WILLEBRAND DISEASE | Ferdow Atiq | |
OR05 | PHASE 1/2 TRIAL OF SINGLE AND MULTIPLE DOSE SUBCUTANEOUSLY ADMINISTERED FACTOR IX VARIANT CB 2679D/ISU304: PHARMACOKINETICS, ACTIVITY AND SAFETY | Howard Levy | |
OR06 | PERIOPERATIVE MANAGEMENT FOR PATIENTS WITH CONGENITAL FACTOR XI DEFICIENCY | Chatree Chai-Adisaksopha | |
OR07 | OCCURENCE AND IMPACT OF PAIN AMONG PATIENTS LIVING WITH HEMOPHILIA: AN ANALYSIS FROM THE PATIENT REPORTED OUTCOMES, BURDENS AND EXPERIENCES (PROBE) STUDY | Mark W. Skinner | |
OR08 | PERIOPERATIVE MANAGEMENT IN PATIENTS WITH HEMOPHILIA RECEIVING FITUSIRAN, AN INVESTIGATIONAL RNAI THERAPEUTIC TARGETING ANTITHROMBIN FOR THE TREATMENT OF HEMOPHILIA | Claude Negrier | |
OR09 | PHARMACOKINETICS (PK), PHARMACODYNAMICS (PD) AND PK/PD RELATIONSHIPS OF EMICIZUMAB IN PERSONS WITH HAEMOPHILIA A (PWHA) WITH INHIBITORS FROM ADOLESCENT/ADULT (HAVEN 1) AND PAEDIATRIC (HAVEN 2) PHASE 3 STUDIES | Christophe Schmitt | |
OR10 | EMICIZUMAB PROPHYLAXIS IN PAEDIATRIC PERSONS WITH HAEMOPHILIA A (PWHA) WITH INHIBITORS: IMPACT ON HEALTH-RELATED OUTCOMES AND CAREGIVER BURDEN IN THE HAVEN 2 STUDY | Maria Elisa Mancuso | |
10:00 – 10:30 | Coffee Break/Poster Viewing | Poster & Catering Area |
10:30 – 12:00 | SESSION 7: Innovations in Haemophilia Treatment | Chairs: Gerry Dolan and Carmen Altisent | Auditorio A / Plenary Hall |
---|---|---|---|
Gene therapy for hemophilia: an update | Frank Leebeek | ||
Immunogenicity of new treatments: Current status of knowledge | David Lillicrap | ||
Factor assays in the era of new therapies | Steve Kitchen |
12:00 – 12:30 | AROSENIUS LECTURE 2018 | Chairs: Víctor Jiménez Yuste and Jan Astermark | Auditorio A / Plenary Hall |
---|---|---|---|
Ageing and haemophilia | Evelien Mauser-Bunschoten |
12:30 – 12:45 | POSTER AND RESEARCH AWARDS | Chair: Michael Makris | Auditorio A / Plenary Hall |
---|
12:45 – 13:45 | SESSION 8: HOT TOPICS | Chairs: Michael Makris and Víctor Jiménez Yuste | Auditorio A / Plenary Hall |
---|---|---|---|
OR11 | ACHIEVEMENT OF NORMAL FACTOR VIII ACTIVITY FOLLOWING BMN 270 AAV5-FVIII GENE TRANSFER: LONG-TERM EFFICACY AND SAFETY FROM A PHASE 1/2 STUDY IN PATIENTS WITH SEVERE HEMOPHILIA A | Benjamin Kim | |
OR12 | SPK-9001: ADENO-ASSOCIATED VIRUS MEDIATED GENE TRANSFER FOR HEMOPHILIA B – SUSTAINED FIX ACTIVITY AND PERSISTENT PROPHYLACTIC BENEFIT AT 1 YEAR | Spencer K. Sullivan | |
OR13 | SPK-8011: PRELIMINARY RESULTS FROM A PHASE 1/2 TRIAL OF INVESTIGATIONAL GENE THERAPY FOR HEMOPHILIA A | Spencer K. Sullivan | |
OR14 | ENDOGENOUS FIX EXPRESSION AND REDUCED ANNUAL BLEED RATE FOLLOWING AMT-060 (AAVHFIX) IN ADULTS WITH SEVERE OF MODERATE-SEVERE HEMOPHILIA B: INTERIM RESULTS UP TO 1.5 YEARS FROM A PHASE I/II DOSE-ESCALATION STUDY | Wolfgang Miesbach |
13:45 – 14:00 | CLOSING REMARKS | Víctor Jiménez-Yuste | Auditorio A / Plenary Hall |
---|---|---|---|
14:00-15:00 | Lunch | Poster & Catering Area |